###begin article-title 0
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 54 <span type="species:ncbi:9606">people</span>
###xml 185 190 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
Several subtypes of HIV-1 circulate in infected people worldwide, including subtype B in the United States and subtype C in Africa and India. To understand the biological properties of HIV-1 subtype C, including cellular tropism, virus entry, replication efficiency and cytopathic effects, we reciprocally inserted our previously characterized envelope V3-V5 regions derived from 9 subtype C infected patients from India into a subtype B molecular clone, pNL4-3. Equal amounts of the chimeric viruses were used to infect T-lymphocyte cell lines (A3.01 and MT-2), coreceptor cell lines (U373-MAGI-CCR5/CXCR4), primary blood T-lymphocytes (PBL) and monocyte-derived macrophages (MDM).
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 193 194 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 199 201 199 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 228 230 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 695 696 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
We found that subtype C envelope V3-V5 region chimeras failed to replicate in T-lymphocyte cell lines but replicated in PBL and MDM. In addition, these chimeras were able to infect U373MAGI-CD4+-CCR5+ but not U373MAGI-CD4+-CXCR4+ cell line, suggesting CCR5 coreceptor utilization and R5 phenotypes. These subtype C chimeras were unable to induce syncytia in MT-2 cells, indicative of non-syncytium inducing (NSI) phenotypes. More importantly, the subtype C envelope chimeras replicated at higher levels in PBL and MDM compared with subtype B chimeras and isolates. Furthermore, the higher levels subtype C chimeras replication in PBL and MDM correlated with increased virus entry in U373MAGI-CD4+-CCR5+.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 315 320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Taken together, these results suggest that the envelope V3 to V5 regions of subtype C contributed to higher levels of HIV-1 replication compared with subtype B chimeras, which may contribute to higher viral loads and faster disease progression in subtype C infected individuals than other subtypes as well as rapid HIV-1 subtype C spread in India.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 777 778 777 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 38 73 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 436 441 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 528 533 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 896 901 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The steepest increase in new cases of human immunodeficiency virus type 1 (HIV-1) infection has taken place in South America [1] and South/Southeast Asia [2], of which India is experiencing a rapid and extensive spread of infection. National surveys in India have shown that the spread in India is primarily heterosexual in the metropolitan and coastal cities, and via intravenous drug use in the Northeast bordering Myanmar [3,4]. The HIV-1 sequences analyzed from different cohorts from several regions in India suggests that HIV-1 subtype C is the predominant subtype found in India [3-8]. It has also been shown in several African and South American studies that subtype C rapidly predominates over all the other HIV-1 subtypes after being introduced in those populations [1,9], suggesting that subtype C may soon become the prevalent subtype worldwide. However, the biological properties of HIV-1 subtype C viruses that may influence its rapid spread are not known.
###end p 9
###begin p 10
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1101 1105 1101 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1394 1396 1394 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1668 1670 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1671 1673 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1674 1676 1674 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1677 1679 1677 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1680 1682 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 236 241 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 401 406 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1273 1278 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1543 1548 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1827 1832 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 envelope gp120 interacts with CD4 receptor and CXCR4 or CCR5 coreceptor [10-13] on T lymphocytes, monocytes/macrophages and other cell types [11,14,15] to enter target cells. Analysis of env gp120 sequences from a large number of HIV-1 isolates shows that gp120 is made up of five variable regions (V1 to V5) that are interspersed with conserved regions [16]. The potential pathogenic region of HIV-1 presumably lies within these variable regions, especially in the V3 region comprising of 35 amino acids arranged in a disulphide loop involving two cysteines [10]. The hypervariable region 3, the V3 region, is functionally important in virus infectivity [17-19], virus neutralization [13,20-22], replication efficiency and host cell tropism [10,23], whereas the V1-V2 regions influence replication efficiency in macrophages by affecting virus spread [24,25]. In addition, the variable loops V4 and V5 of gp120 are less flexible regions of the proteins and may play roles in CD4 binding and neutralizing antibody responses [26,27]. The mechanisms by which the V3 domain and other regions of the env glycoprotein control cell tropism were described by identifying two distinct co-receptors, fusin (CXR4) and CCR5, for the entry of T-lymphotropic and macrophage-tropic HIV-1, respectively [11,15]. The region responsible for determining coreceptor utilization was examined by Choe et al., [12] and showed that the V3 region was responsible for interacting with this co-receptor. Several studies have shown that a reciprocal transfer of an HIV-1 R5 clones' V3 region into an X4 molecular clone changed its tropism to allow infection and replication in macrophages [10,19,23,28-30]. However, most of the data on viral infectivity, coreceptor utilization, replication efficiency and cytopathic effects have been obtained from HIV-1 subtype B, and very limited information is available on subtype C viruses, especially those from India.
###end p 10
###begin p 11
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 216 224 <span type="species:ncbi:9606">patients</span>
###xml 334 339 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 373 378 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
###xml 747 752 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we have characterized the biological properties of HIV-1 subtype C envelope V3 to V5 regions by constructing chimeric recombinant viruses containing subtype C envelope V3-V5 regions from nine infected patients from India [5] into subtype B infectious molecular clone, pNL4-3. We show that the envelope V3-V5 regions of HIV-1 subtype C changed the tropism of HIV-1 NL4-3 from X4 to R5 and contributed to the increased virus entry and replication efficiency in primary blood T-lymphocytes (PBL) and monocyte-derived macrophages (MDM) compared with subtype B viruses. This higher replication efficiency of subtype C compared with subtype B may contribute to a higher viral load and faster disease progression in patients infected with HIV-1 subtype C viruses in the Indian population.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Characterization and comparison of subtype C envelope V3-V5 chimeras' sequences with known isolates
###end title 13
###begin p 14
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 473 478 473 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 485 489 485 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL </sub>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 568 572 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 634 638 634 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL </sub>
###xml 648 653 648 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 845 850 845 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ba-L </sub>
###xml 1072 1078 1072 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 1475 1481 1475 1481 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 1605 1608 1605 1608 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL</sub>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 267 274 <span type="species:ncbi:9606">patient</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 341 344 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 468 471 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 480 483 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 629 632 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 643 646 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 840 843 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 937 944 <span type="species:ncbi:9606">patient</span>
###xml 1067 1070 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1338 1345 <span type="species:ncbi:9606">patient</span>
###xml 1470 1473 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1600 1603 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We confirmed the reciprocal insertion of the sixteen envelope V3-V5 region sequences (Fig. 1) from nine subtype C infected patients' isolates from India (Table 1) that were sequenced before [5] into pNL4-3 by nucleotide sequencing. Two clones were selected from each patient for reciprocal insertion. The patients harbored various stages of HIV disease (I to IVE) based on the 1987 CDC classification. We also compared the subtype C env V3 to V5 regions chimeras with HIV-1NL4-3, HIV-1BaL and a known env V3-V5 region sequence of subtype C (Fig. 1). All the subtype C env V3-V5 clones showed a greater similarity to the R5 virus HIV-1BaL than HIV-1NL4-3. The amino acids critical for the R5 phenotype, including the Y at position 283 and E or D at position 287 were present in all subtype C clones. The amino acid H at position 275 seen in HIV-1Ba-L which is also important for determining R5 tropism was present only in the clones from patient 17 (clones 171 and 173). The amino acid sequences between positions 310-315 and 350-373 were significantly different from HIV-1NL4-3 clone but were very similar to the previously known sequence of subtype C envelope region. It is interesting to note that a critical glycosylation site, which includes the first cysteine of the V3 loop, was mutated in all the clones except those obtained from patient 17 and 5 (clones 171, 173, 512, 514). The sequence analysis of all the clones indicate that these clones are different from HIV-1NL4-3 envelope sequences but very similar to envelope sequences from known subtype C clones and to R5 tropic viruses such as HIV-1BaL.
###end p 14
###begin p 15
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 259 265 259 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 289 293 289 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL </sub>
###xml 254 257 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 284 287 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 303 308 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Comparison of envelope (V3 to V5 regions) from subtype C chimeras with subtype B (X4 and R5) and C envelope sequences. The sequences of subtype C env chimeras used in this study were analyzed by performing multiple sequence alignment with parental clone HIV-1NL4-3 as a reference and HIV-1BaL and known HIV-1 subtype C envelope regions for comparison. Subtype C chimeras are designated by numbers. Dots indicate a match with the reference sequence whereas substitutions are indicated by the single letter code for the changed amino acid. Gaps are shown as dashes. Structural elements of the envelope are indicated by spanning arrowheads and glycosylation sites are indicated by asterisk. Amino acid positions are indicated to denote the amino acid numbers of the complete envelope gp120.
###end p 15
###begin p 16
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient demographics, possible source and risk factor of transmission and CDC disease classification.
###end p 16
###begin p 17
CDC-Center for Disease Control and Prevention
###end p 17
###begin title 18
Computational prediction of coreceptor usage using V3 amino acid sequence of subtype C chimeras
###end title 18
###begin p 19
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 991 992 991 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 130 137 <span type="species:ncbi:9606">patient</span>
###xml 1065 1070 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We also used the Position Specific Scoring Matrix (PSSM) bioinformatics tool (X4/R5) to predict coreceptor usage by the Subtype C patient env V3-V5 region sequences [31] and calculated scores for each clone are shown in Table 2. A score of -6.96 was used as a cut off for R5 strains and a score of -2.88 was used as a cutoff for X4 strains. Most of these scores were higher than -6.96 especially AP.17 sequence which showed a score of -3.58 clearly below the cut-off score for X4 strains. Thus, all the clones were clearly predicted to be R5 tropic. We also used the PSSM (sinsi) matrix to analyze these sequences and these scores were in the range of -7.5 to -11.53. This predicts high R5 tropism and a NSI phenotype for all the Indian isolates examined. Higher numbers of positively charged amino acids (R/K/H) have been correlated with the likelihood of CXCR4 use. In all of the Indian sequences in this study, lower numbers of positive charges, in the range of 5 to 7, were found (Table 2). Thus, in an in-silico prediction model, all of the V3-V5 sequences of HIV-1 Indian isolates were predicted to show R5-tropism.
###end p 19
###begin p 20
Prediction of coreceptor usage by Position Specific Scoring Matrix (PSSM) bioinformatics tool that predicts coreceptor usage.
###end p 20
###begin title 21
Replication of subtype C chimeric viruses in T-Lymphocyte cell lines
###end title 21
###begin p 22
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 128 134 128 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 230 235 230 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 348 354 348 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 697 703 697 703 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 123 126 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 225 228 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 343 346 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 692 695 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 741 749 <span type="species:ncbi:9606">patients</span>
###xml 949 956 <span type="species:ncbi:9606">patient</span>
We first sought to determine whether the subtype C env chimeras retained the lymphotropic properties of the parental clone HIV-1NL4-3 by infecting the T cell line A3.01 with the subtype C chimeric viruses and parental virus, HIV-1NL4-3. The T-cell line A3.01 expresses CD4 and CXCR4 but no CCR5. Our results showed that the parental X4 tropic HIV-1NL4-3 productively infected and replicated in A3.01 over a 27-day infection period. However, the subtype C chimeras did not replicate in A3.01 cell line (Fig. 2), suggesting that these chimeras were no longer T-cell line tropic, unlike the parental clone. These results further demonstrated that replacement of the V3-V5 regions of envelope of HIV-1NL4-3 with subtype C envelope from infected patients was responsible for the lack of capacity to use CXCR4 as a coreceptor for these chimeric viruses. These data also suggest that the integrated proviruses that were present in these subtype C infected patient samples were not X4 tropic.
###end p 22
###begin p 23
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 222 228 222 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 237 240 237 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL</sub>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 217 220 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 232 235 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Replication of HIV-1 subtype C env V3-V5 region chimeras in T-lymphocyte (A3.01) cell line. A3.01 cells (1 x 106 cells/well) were infected with equal amounts (RT counts) subtype C env chimeras (171 to 1014), parental HIV-1NL4-3 and HIV-1BaL. Virus production was measured by reverse transcriptase (RT) assay in culture media harvested every 3 days and the cells fed with appropriate media. The results are presented as cpm/ml +/- SD of five separate triplicate experiments. The subtype C chimeras were unable to replicate in A3.01 cell line.
###end p 23
###begin title 24
Coreceptor utilization of chimeric subtype C viruses
###end title 24
###begin p 25
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 505 510 502 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 529 532 526 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL</sub>
###xml 596 597 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 617 621 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 1968 1969 1965 1966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1970 1972 1967 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1973 1975 1970 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 425 430 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 500 503 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 524 527 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1543 1548 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1567 1574 <span type="species:ncbi:9606">patient</span>
###xml 1633 1640 <span type="species:ncbi:9606">patient</span>
###xml 1903 1910 <span type="species:ncbi:9606">patient</span>
###xml 2030 2035 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We then determined the coreceptor utilization of the subtype C env chimeras (clone designation in Fig. 1 and Table 1) using U373-MAGI indicator cell lines. These cell lines express the CD4 receptor in conjunction with either CCR5 or CXCR4 as a coreceptor and can be infected with either macrophage tropic (R5) or lymphotropic (X4) viruses, respectively. These cells contain an inducible beta-galactosidase reporter driven by HIV-1 LTR that can be used as an indicator for entry. The known SI isolate HIV-1NL4-3, NSI isolate HIV-1BaL, and primary isolates were used as controls. As shown in Table 3, all the subtype C env chimeras were able to infect the U373-MAGI-CCR5 cell line but were unable to infect the U373-MAGI-CXCR4 cell line. This data also correlates well with the insilico prediction models and confirms the coreceptor usage of these viruses. This data suggests that the cloning of these chimeras yielded functional envelope regions that can bind CD4/CCR5 and allow virus entry and production of early viral genes. As seen by the counts for infectivity of the MAGI-CCR5 line, the chimeras showed considerable differences in infectivity. Some chimeras (171, 173) demonstrated remarkably high levels of infectivity when compared to other chimeras and primary isolate controls indicating an increased rate of entry for these chimeras. The levels of entry using increasing virus counts (5000 and 10,000 RT counts) during infection showed increased level of entry for the same chimeras. This shows that the envelope region of subtype C HIV-1 obtained from the patient samples shows an R5 phenotype for the virus infecting the patient. These results also suggest that all the chimeric viruses obtained could have had different rates of entry when infecting target cells. This can be attributed to the differences in the V3 region of the subtype C chimeric DNA, reflecting the differences found in patient samples. This also adds to previous work done by others [4,32,33] showing that the coreceptor utilization of subtype C HIV-1 could be predominantly R5 even late in infection.
###end p 25
###begin p 26
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Coreceptor usage by HIV-1 subtype C chimeras in U373-MAGI-CCR5 and U373-MAGI-CXCR4 cell lines.
###end p 26
###begin p 27
NSI - non-syncytium inducing, SI - syncytium inducing, - indicate no entry due to lack of blue cells.
###end p 27
###begin title 28
Syncytium inducing capacity of subtype C chimeras
###end title 28
###begin p 29
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 365 366 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 530 533 530 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL</sub>
###xml 568 574 568 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 898 903 898 903 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 1028 1032 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 525 528 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 563 566 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 834 841 <span type="species:ncbi:9606">patient</span>
###xml 893 896 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We examined the syncytium-inducing ability of the subtype C env chimeras by infecting MT-2 cell lines with the chimeric viruses. Viruses that produce a greater than four syncytia per field were denoted as syncytium inducing (SI) phenotype and the viruses that did not induce any syncytia were called as non-syncytium inducing (NSI) phenotype. As shown in the Table 3, all of the subtype C V3-V5 region chimeras failed to produce any syncytia in MT-2 cells and therefore are of the NSI phenotype (similar to known R5 isolates HIV-1BaL). The control parental virus HIV-1NL4-3 that has a known SI phenotype produced significant levels of syncytia (at least 10 per field of view). As expected, the R5 viruses used as control also did not produce syncytia in culture. These data suggest that the envelope sequences from subtype C infected patient samples render them less cytopathic as compared to HIV-1NL4-3. We also confirmed virus production in MT-2 cells and the syncytium formation correlated to virus production in our partial env (V3-V5) region chimeras (NSI) and R5 isolates as measured by RT assay in the culture medium (not shown).
###end p 29
###begin title 30
Replication of subtype C chimeras in primary peripheral blood T-lymphocytes
###end title 30
###begin p 31
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 447 454 <span type="species:ncbi:9606">patient</span>
Primary T-lymphocytes from peripheral blood express CD4 and both chemokine receptors, CXCR4 and CCR5. Since PBL express both CCR5 and CXCR4, they are capable of supporting the replication of both R5 and X4 tropic viruses. All the subtype C env chimeras, which did not replicate in A3.01, were able to replicate in PBL showing that there was no inherent defect in their replication as a results of the reciprocal insertion of the V3-V5 region from patient samples (Fig. 3). Although we have demonstrated the entry of these chimeric viruses using the MAGI cell experiments, the replication kinetics shown in Figure 3 confirm the capacity of these viruses to enter and replicate well in culture.
###end p 31
###begin p 32
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 366 371 366 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 361 364 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Replication of HIV-1 subtype C env V3-V5 region chimeras in primary peripheral blood T-lymphocytes (PBL). PBL (1 x 106 cells/well) were stimulated with PHA and infected with equal amounts (reverse transcriptase counts) of subtype C env V3-V5 region chimeras, subtype B env V3 region chimeras, primary subtype B isolates, primary subtype C isolates and parental HIV-1NL4-3. Cells were fed every 3 days with appropriate medium and virus production was measured in the culture supernatant by RT assay. The data are presented as cpm/ml +/- SD on triplicate experiments and are based on PBL from five different donors.
###end p 32
###begin p 33
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 806 807 806 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 882 883 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1354 1355 1354 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1410 1411 1410 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1840 1841 1840 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1894 1895 1894 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 379 386 <span type="species:ncbi:9606">patient</span>
###xml 1688 1693 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1878 1886 <span type="species:ncbi:9606">patients</span>
The replication kinetics of subtype C chimeras in PBL showed that these chimeras replicated at a higher efficiency as compared to subtype B chimeras (M5g, M7f, and M1c [34]) and subtype B isolates. Close observation showed that chimeras 171 and 173 replicated and peaked much earlier in infection as compared to the other chimeras. The V3-V5 region of these chimeras came from a patient who demonstrated advanced disease (Table 1) [5]. Although some chimeras (284 and 331) peaked relatively late in infection, they peaked at higher levels than the subtype B chimeras. All the subtype C chimeras also replicated at levels higher than the subtype B primary isolates. The replication data of the subtype C chimeras (Fig. 3) correlated well with the rate of entry seen in the MAGI cell line experiments (Table 3). The chimeras that scored higher numbers in MAGI cell experiments (Table 3) peaked earlier in viral infection experiments (Fig. 3). Comparative rates of entry of chimeras correspond with the peak of viral replication, where 171 and 173 with highest level of entry in MAGI cells showed very early and high peaks and 284 and 331 chimeras with much lower level of entry showed lower and/or more delayed peaks. It is interesting to note that chimeras 171, 173, 512 and 514, which retained the first proximal glycosylation site of the V3 region (Fig 1), peaked very early (Day 6-9) during replication (Fig 3). Comparison of the primary isolates of subtype B and subtype C also showed that the subtype C primary isolates replicated better than the subtype B primary isolates. These data suggest that the envelope V3 to V5 regions of the subtype C influenced the rate of replication of HIV-1 in primary T-lymphocytes and determined the cellular tropism. Furthermore, there was a direct relationship between higher viral replication (Fig. 3) and advanced disease status of the patients (Table 1).
###end p 33
###begin title 34
Replication of subtype C chimeras in primary monocyte-derived macrophages
###end title 34
###begin p 35
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1184 1189 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
While primary monocyte derived macrophages (MDM) express CD4 and CCR5 and a low level of CXCR4, they support productive infection of R5 but not X4 viruses. As the subtype C chimeras showed a R5 phenotype (Table 3), replication kinetics of these chimeras were evaluated in MDM. Figure 4 shows the replication kinetics of subtype C chimeras in comparison with primary subtype B and C controls. The data clearly demonstrated that subtype C chimeras replicated better than subtype B viruses. The rate of replication of the subtype C chimeras in MDM also correlated with the rate of entry of the chimeras in MAGI-CCR5 cell line, further supporting the hypothesis that the increase in the replication of these chimeras is due to increase in the rate of entry. Both subtype B (2099) and subtype C (3041) primary R5 isolates replicated in MDM and subtype B dual tropic (X4/R5) virus (2101) also showed adequate replication in MDM. In addition, comparison of subtype B and subtype C primary isolates also showed that the subtype C primary isolates replicated better than subtype B primary isolates. These data suggest that the V3 to V5 regions of subtype C influenced increased replication of HIV-1 in MDM.
###end p 35
###begin p 36
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 286 289 286 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL</sub>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 281 284 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Replication of HIV-1 subtype C env V3-V5 region chimeras in primary blood monocyte-derived macrophages (MDM). MDM (0.5 x 106 cells/well) were infected with equal amounts (RT counts) of subtype C env V3-V5 region chimeras, primary subtype B isolates, primary subtype C isolates and HIV-1BaL. Cells were fed every 3 days with appropriate medium and the virus production was measured in the culture supernatant by RT assay. The data are presented as cpm/ml +/- SD on triplicate experiments and are based on MDM from five different donors.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 946 948 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 105 113 <span type="species:ncbi:9606">patients</span>
###xml 329 334 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
###xml 510 515 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
###xml 802 807 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We have provided evidence regarding the role of the HIV-1 envelope V3-V5 regions from subtype C infected patients from India in virus entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and macrophages in comparison with those of subtype B viruses. Our data suggest that the reciprocal insertion of HIV-1 subtype C infected patients' envelope V3 to V5 regions [5] into subtype B molecular clone, contributed to utilization of CCR5 coreceptor (Table 3) as well as higher levels of HIV-1 entry and replication efficiencies in primary T-lymphocytes (Fig. 3) and MDM (Fig. 4). The higher viral replication efficiencies of R5 phenotype of the chimeras correlated with advanced disease status of the patients (Table 1). Taken together, the increased replication capabilities of HIV-1 subtype C in T-lymphocytes and MDM may contribute to a high viral load, rapid disease progression, and spread in infected individuals [35,36].
###end p 38
###begin p 39
###xml 427 432 427 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 832 833 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1035 1038 1035 1038 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL</sub>
###xml 1096 1102 1096 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 1139 1140 1139 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1344 1346 1344 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1353 1355 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 422 425 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 716 723 <span type="species:ncbi:9606">patient</span>
###xml 1030 1033 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1091 1094 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We have demonstrated that subtype C envelope V3-V5 region chimeras showed increased levels of virus entry that correlated with an increased rate of replication in primary T-lymphocytes and MDM compared with subtype B chimeras and subtype B primary isolates. Careful observation indicates that chimeras with higher rate of entry peaked earlier during infection in primary cells. Unlike the lymphotropic (X4) parental clone HIV-1NL4-3, the subtype C env V3-V5 region chimeras were unable to replicate in T lymphocyte cell lines A3.01 (Fig. 2) and MT-2 (Table 3), suggesting that the chimeras had lost the T-cell line tropism of the parent clone NL4-3 because of reciprocal insertion of the V3-V5 region from subtype C patient samples. In addition, all of the subtype C env chimeras failed to produce any syncytia in MT-2 cells (Table 3), denoting NSI phenotypes, similar to the R5 but not NL4-3 isolates. Infection of U373-Magi-X4 and U373-Magi-R5 cell lines indicate that all our chimeric viruses and the control R5-tropic isolate HIV-1BaL, utilized the CCR5 coreceptor, whereas the parental HIV-1NL4-3 utilized the CXCR4 coreceptor (Table 3). These results are consistent with earlier reports that showed reciprocal insertion of the V3 region of an R5 isolate into an X4 molecular clone altered the tropism of an X4 isolate to an R5 phenotype [10,19,23,28-30].
###end p 39
###begin p 40
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 580 581 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 855 856 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
###xml 518 526 <span type="species:ncbi:9606">patients</span>
###xml 561 564 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
###xml 709 717 <span type="species:ncbi:9606">patients</span>
###xml 816 824 <span type="species:ncbi:9606">patients</span>
Our in-silico analysis of the V3 sequences of the subtype C isolates from India predicted R5 tropism (Table 2). This also explains why these viruses replicated in primary blood Tlymphocytes (Fig. 3) but failed to replicate in the T4 lymphocyte cell lines, A3.01 (Fig. 2) and MT-2 because primary T-lymphocytes express CCR5, whereas and A3.01 and MT-2 do not. This data further supports the predominance of R5 phenotype in subtype C infected patients [37,38] and its maintenance during symptomatic AIDS. Several of the patients that exhibited advanced stages of HIV disease (Table 1) also harbored R5 phenotype (Table 2, 3), rarely seen in subtype B infected adult patients. In addition, the chimeras from the patients with advanced disease status (III, IV) replicated more efficiently than the less advanced disease patients (I, II) [Table 1, Figs. 3 and 4]. Furthermore, it has also been found that the percentage of CD4 T cells expressing CCR5 in Indian adults is higher than among Caucasian races [39]. It is, therefore, likely that due to the presence of this larger pool of CCR5 positive CD4 cells, the virus may not need a coreceptor switch during disease progression.
###end p 40
###begin p 41
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 167 173 167 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1091 1095 1091 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BAL </sub>
###xml 1118 1119 1118 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1202 1206 1202 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BAL </sub>
###xml 1214 1215 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 162 165 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 668 675 <span type="species:ncbi:9606">patient</span>
###xml 1049 1052 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1086 1089 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1197 1200 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Our data showed that subtype C V3-V5 region chimeras replicated better in primary blood T-lymphocytes (Fig. 3) and MDM (Fig. 4) compared with subtype B chimeras, HIV-1NL4-3 and subtype B primary isolates. In general, there was a correlation between higher virus entry, earlier replication peaks, and increased replication efficiencies in primary T-lymphocytes and MDM. Examination of sequence data published earlier on these patients [5] and presented in Fig. 1 and Table show several features of subtype C chimeras, including number of positive charges, amino acid sequence variation and number of glycosylation sites. One striking feature was that the chimeras from patient AP.17 (chimeras # 171, 173) and AP.5 (chimeras # 512, 514) retained the N-linked glycosylation site that includes the first cysteine residue of V3 loop [10], whereas other chimeras had mutations in this site, contributing to the differences in replication efficiencies of these chimeras (Fig. 3). Our subtype V3-V5 region chimeras were in close resemblance with subtype C (HIV-1C) with V3 sequences similar to HIV-1BAL (R5), as shown in Fig. 1. The motif SIHIGPGRALYTTGEIIGDI that is important for R5 tropism as seen for HIV-1BAL in Fig. 1 was fairly conserved in our subtype C chimeras contributing to R5 tropism. Similarly subtype C chimeras V4-V5 region sequences show similarity to subtype C sequence but variability to subtype B (X4 and R5) sequences. The difference in amino acid sequences in V3 to V5 regions in subtype C chimeras as compared to subtype B sequences may be responsible for increased replication efficiencies of subtype C chimeras. Further studies on site directed mutagenesis of the V3-V5 regions and binding affinity of gp120 to CCR5 and/or gp120 incorporation into chimeric virions might pinpoint the major difference in replication efficiencies.
###end p 41
###begin p 42
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 164 172 164 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in-vivo </italic>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 550 558 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 730 732 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 733 735 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 888 889 884 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 890 891 886 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1062 1064 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1065 1067 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1068 1070 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 193 208 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 225 230 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 415 420 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 872 877 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
While a co-infection in vitro study with more fit subtype B and less fit subtype C viruses indicates more fitness of subtype B over subtype C viruses [40], several in-vivo infection studies on rhesus macaques have shown that HIV-1 subtype C env chimeric viruses demonstrate greatly enhanced infectivity [41-43] and replication efficiency as compared to subtype B and E viruses [44,45]. Our data on higher levels of HIV-1 entry and increased replication efficiencies of subtype C chimeras compared with subtype B viruses is consistent with the latter in vivo studies [41-43]. Increased replication efficiency of subtype C viruses has also been attributed to the presence of an extra NF-kappaB site in the LTR of subtype C viruses [46,47]. However, these viruses have shown not only to replicate efficiently but to also be transmitted and spread more efficiently than other HIV-1 subtypes [1,9]. During horizontal and vertical transmission subtype C viruses have been shown to spread more rapidly than other subtypes due to increased mucosal and vaginal shedding [36,48,49]. This increased transmission cannot solely be explained due to increased LTR activity as increased shedding of virus and increased transmission may be attributed to the envelope gene and others regions and functions of the virus.
###end p 42
###begin p 43
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 174 179 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 316 321 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
###xml 529 534 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 655 660 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 853 858 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
While various HIV-1 subtypes prevalent in different regions of the world show variability in their replication kinetics and disease progression in infected individuals [32], HIV-1 subtype C is rapidly spreading and has already become the predominant subtype worldwide. The data presented in this paper indicate that HIV-1 envelope V3-V5 region of subtype C contributes to increased rates of replication as compared to subtype B. This would also explain higher viral loads and faster disease progression in patients infected with HIV-1 subtype C [35] as well as increased shedding of virus seen in subtype C infected population [36,48]. Our data shows the HIV-1 subtype C envelope V3-V5 region may be one of the determinants of increased virus entry and replication. These results provide another candidate gene to be responsible for the rapid spread of HIV-1 subtype C and its ability to dominate in populations that initially had higher incidence of other subtypes.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Construction of HIV-1 Chimeras
###end title 45
###begin p 46
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 314 320 314 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3 </sub>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 674 677 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 719 722 719 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 826 829 826 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 864 867 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 873 876 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 955 958 955 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1037 1040 1037 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 1157 1160 1157 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1163 1166 1163 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 1483 1486 1483 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1489 1492 1489 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 1498 1501 1498 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 309 312 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1320 1327 <span type="species:ncbi:9606">patient</span>
###xml 1375 1382 <span type="species:ncbi:9606">patient</span>
Sixteen previously characterized envelope V3-V5 region sequences (Fig. 1) from nine subtype C Indian isolates (Table 1) [5] were reciprocally substituted into pNL4-3 in BglII-BglII sites flanking the region. The 650 bp fragment encompassing the V3-V5 region corresponds to amino acids 240-439 of gp120 of the HIV-INL4-3 sequence with the V3-loop positioned between amino acids 267 and 300. PCR primers were designed to amplify the V3-V5 region and to replace a similar region in pNL4-3 by engineering a BglII site at the 3' end at position 7611 corresponding to all isolates. PCR amplification was carried out using Pfu polymerase. The ~600 bp PCR product was digested with BglII and cloned into pGEM (NL4-3) using the BglII sites [50]. The BglII-BglII fragment was reciprocally exchanged into the pGEM plasmid containing the EcoRI-BamHI fragment as there were no EcoRI or BamHI sites in this a region in any Indian isolate except AP.5 which contained an EcoRI site in the sequence. The recombinant clones were checked by digestion with BglII and the orientation was confirmed by DNA sequencing using primer (5'TCAACTGCTGTTAAATGGC3'). Finally, the modified EcoRI-BamHI fragment containing the sporadic subtype C Indian isolate V3 to V5 region was reciprocally substituted into pNL4-3. Two clones were obtained from each patient sample and these are numbered with numerals of patient identification number followed by clone number. All the clones were again checked by digestion with EcoRI/SalI and BamHI and confirmed by sequencing.
###end p 46
###begin title 47
Cell lines and primary cells
###end title 47
###begin p 48
###xml 1502 1504 1501 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 95 101 <span type="species:ncbi:9913">bovine</span>
###xml 647 652 <span type="species:ncbi:9606">Human</span>
###xml 762 767 <span type="species:ncbi:9606">Human</span>
###xml 1537 1542 <span type="species:ncbi:9606">human</span>
###xml 2059 2064 <span type="species:ncbi:9606">human</span>
HeLa cells, U373-MAGI-CXCR4 and U373-MAGI-CCR5 cell lines were cultured in DMEM with 10% fetal bovine serum (FBS) and penicillin-streptomycin (Invitrogen). The MAGI cell media was also supplemented with 0.2 mg/ml of G418, 0.1 mg/ml of hygromycin B and 1 mug/ml of puromycin. T-lymphocyte cell lines, A3.01 and MT-2 were cultured in RPMI 1640 supplemented with 10% FBS and penicillin-streptomycin. Peripheral blood mononuclear cells (PBMC) were obtained by single step density gradient centrifugation with Ficoll-Hypaque (Amersham) from whole blood of normal donors. The blood collections were made after informed consent, and were approved by the Human Subject Ethical committees of International Center for Genetic Engineering and Biotechnology (ICGEB) and the Human Subjects Committee of the University of Arizona (Tucson, AZ) and were based on Indian Council of Medical Research (ICMR) and National Institutes of Health (NIH) guidelines, respectively. PBMC were collected, washed twice with cold PBS and centrifuged at 1000 rpm for 10 min to avoid collecting platelets. Primary monocyte/macrophages and peripheral blood lymphocytes (PBL) were separated from PBMC using magnetic bead isolation protocols. Monocytes were isolated by CD14 magnetic bead isolation (Miltenyi biotech) according to the manufacturer's protocols. The cells bound to the CD14 bead were used as primary monocytes. The primary monocytes eluted from the CD14 isolation columns were counted and plated in 48 well plates at 1 x 106 cells/well in RPMI 1640 with 15% human AB serum (Gemini biotech) and MCSF (Sigma) for 7 days and were allowed to differentiate into macrophages in this media. The cells were fed every two days during differentiation. The cells collected as unbound flow through from the CD14 bead isolation protocol were used as PBL. PBL were cultured in RPMI 1640 with 10% FBS and penicillin-streptomycin. PBL were stimulated with 5 mug/ml of PHA for 24-48 h. The stimulated cells were washed with PBS and resuspended in RPMI 1640 with 10% FBS and 20 U/ml of recombinant human IL-2 (Invitrogen).
###end p 48
###begin title 49
DNA Transfections
###end title 49
###begin p 50
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 350 352 350 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 701 703 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 704 706 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
Subtype C chimeric proviral DNAs were transfected in HeLa cells by electroporation as described before [34] or by Lipofectamine 2000 (Invitrogen) [51]. For the Lipofectamine method, HeLa cells were grown in DMEM with 10% FBS and penicillin-streptomycin to about 80% confluency. The cells were then split and counted and plated in a 6-well plate at 105 cells/well in DMEM with 10% FBS without antibiotics. The cells were transfected the next day with 3 mug DNA in DNA-lipofectamine complexes as per manufacturer's procedure. Chimeric viruses were harvested by collecting culture supernatant from the wells 72 hrs post-transfections. Virus production was measured by a reverse transcriptase (RT) assay [34,51].
###end p 50
###begin title 51
Infections
###end title 51
###begin p 52
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">env </italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 597 598 591 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 794 796 780 782 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
A3.01 cells (2 x 106), MT-2 (2 x 106), PBL (1 x 106) and MDM (0.5 x 106) per well were cultured and infected with equal amounts of subtype C env region chimeras, subtype B V3 region chimeras (M5g, M7f, M1c) [34,50], subtype B and C primary isolates, and virus production was measured every 3 days. We used two subtype C (3041-R5 and 5441-X4) and two subtype B (2099-R5 and 2101-X4/R5) primary isolates that were obtained from AIDS Research and Reference Reagent Program as controls. Briefly, viruses were adsorbed in A3.01 cells, MT-2 and PBL for 90 min in serum free media at 37degreesC and 5% CO2. After incubation, 500 mul of appropriate media containing serum and antibiotics were added. MDM were infected in media containing serum and polybrene (8 mug/ml) incubated at 37degreesC and 5% CO2 for 16 hrs. After incubation, the macrophages were washed in PBS to remove polybrene and resuspended in macrophage culture media.
###end p 52
###begin title 53
Coreceptor utilization
###end title 53
###begin p 54
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 778 780 776 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
U373-MAGI-CXCR4 and U373-MAGI-CCR5 cell lines were plated at ~6 x 104 cells/well in 24 well plate in complete DMEM with G418-hygromycin-puromycin. Both cells lines were infected with 5,000 and 10,000 cpm (RT assay counts) of chimeric subtype C virus and primary isolate controls diluted in a total volume of 300 mul of complete DMEM (without antibiotics) with DEAE-dextran (final concentration 20 mug/ml). Two hours post-adsorbtion, 1.5 ml of fresh MAGI media was added. To assess the rate of entry, 40 h post-infection, the medium was removed and cells were fixed in 1% formaldehyde and 0.2% glutaraldehyde for 5 min. Then, the cells were washed with PBS and stained for 2 hrs in staining solution containing 0.2 M potassium ferricyanide, 0.2 M potassium ferrocyanide, 2 M MgCl2 and 40 mug/ml X-Gal. After staining, the cells were washed in PBS and resuspended in PBS with Sodium Azide. Cells stained blue were counted immediately and counts were estimated as number of blue cells per well of infected cells.
###end p 54
###begin title 55
Cytopathic effects (MT-2 assay)
###end title 55
###begin p 56
###xml 141 146 141 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink">NL4-3</sub>
###xml 197 201 197 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">BaL </sub>
###xml 210 215 210 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink">Ada-M</sub>
###xml 136 139 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 192 195 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 205 208 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The syncytium-inducing ability of the subtype C envelope chimeras was determined and compared to a known syncytium-inducing (SI) virus (HIV-1NL4-3) and a non-syncytium-inducing (NSI) viruses (HIV-1BaL and HIV-1Ada-M) by infecting the MT-2 cell line with equal amounts of these viruses. Syncytium formation was monitored every day in the cultures up to 30 days post-infection. The viruses that formed more than four syncytia per field of view in the culture were designated as SI viruses (ACTG protocol), whereas viruses that failed to induce this number of syncytia in the culture were termed NSI viruses.
###end p 56
###begin title 57
Competing interests
###end title 57
###begin p 58
The author(s) declare that they have no competing interests.
###end p 58
###begin title 59
Authors' contributions
###end title 59
###begin p 60
###xml 303 311 <span type="species:ncbi:9606">patients</span>
VS and SRD contributed equally to this work. SRD carried out the PCR, cloning, and sequencing. VS performed all biological experiments, including T-cells lines and primary cells infection experiments. RR contributed in transfections and infection experiments. SS and SG contributed to the collection of patients' samples and clinical data. VS, SRD, RR, NA and SJ participated in the experimental design, data interpretation and writing of the manuscript. All the authors read and approved the final manuscript.
###end p 60
###begin title 61
Acknowledgements
###end title 61
###begin p 62
###xml 642 647 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
This work was supported by an international collaborative grant to NA and SJ by Fogarty International Center, National Institutes of Health (TW 01345) and grants to NA by National Institute of Allergy and Infectious Diseases (AI 40378) and Arizona Biomedical Research Commission (ABRC 7002). Work in the SJ laboratory is also supported by internal funds from ICGEB, which in turn is supported by core funding provided by the Department of Biotechnology, Government of India. SRD was supported by a Senior Research Fellowship from Council of Scientific and Industrial Research, India. We thank AIDS Reference and Reagent Program for providing HIV-1 isolates and cell lines and Roshni Mehta and Brian Wellensiek of Ahmad Lab for critically reviewing this manuscript.
###end p 62
###begin article-title 63
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 subtype C dissemination in southern Brazil
###end article-title 63
###begin article-title 64
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?
###end article-title 64
###begin article-title 65
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV type 1 subtypes circulating in eastern and northeastern regions of India
###end article-title 65
###begin article-title 66
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences
###end article-title 66
###begin article-title 67
###xml 22 27 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants
###end article-title 67
###begin article-title 68
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
nef sequences of primary HIV type 1 isolates from northern India
###end article-title 68
###begin article-title 69
###xml 28 63 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India
###end article-title 69
###begin article-title 70
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India
###end article-title 70
###begin article-title 71
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi
###end article-title 71
###begin article-title 72
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
###end article-title 73
###begin article-title 74
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
###end article-title 74
###begin article-title 75
###xml 36 64 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides
###end article-title 75
###begin article-title 76
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A new classification for HIV-1
###end article-title 76
###begin article-title 77
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
###end article-title 77
###begin article-title 78
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
###end article-title 78
###begin article-title 79
###xml 22 27 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity
###end article-title 79
###begin article-title 80
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain
###end article-title 80
###begin article-title 81
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Effect of a single amino acid substitution in the V3 domain of the human immunodeficiency virus type 1: generation of revertant viruses to overcome defects in infectivity in specific cell types
###end article-title 81
###begin article-title 82
###xml 34 62 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
###end article-title 82
###begin article-title 83
###xml 37 72 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein
###end article-title 83
###begin article-title 84
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein
###end article-title 84
###begin article-title 85
###xml 35 70 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo
###end article-title 85
###begin article-title 86
###xml 56 91 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody
###end article-title 86
###begin article-title 87
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread
###end article-title 87
###begin article-title 88
Contribution of hypervariable domains to the conformation of a broadly neutralizing glycoprotein 120 epitope
###end article-title 88
###begin article-title 89
###xml 116 151 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1
###end article-title 89
###begin article-title 90
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
###end article-title 90
###begin article-title 91
###xml 51 86 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes
###end article-title 91
###begin article-title 92
###xml 89 124 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1
###end article-title 92
###begin article-title 93
###xml 106 141 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences
###end article-title 93
###begin article-title 94
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genetic diversity of HIV-1: the moving target
###end article-title 94
###begin article-title 95
###xml 40 43 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 93 98 <span type="species:ncbi:9606">child</span>
Phylogenetic and phenotypic analysis of HIV type 1 env gp120 in cases of subtype C mother-to-child transmission
###end article-title 95
###begin article-title 96
###xml 31 34 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 79 86 <span type="species:ncbi:9606">infants</span>
Biological characterization of HIV type 1 envelope V3 regions from mothers and infants associated with perinatal transmission
###end article-title 96
###begin article-title 97
###xml 29 64 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India
###end article-title 97
###begin article-title 98
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS
###end article-title 99
###begin article-title 100
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 139 144 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses
###end article-title 100
###begin article-title 101
###xml 126 131 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with the low frequency of X4 phenotype of HIV-1 in India
###end article-title 101
###begin article-title 102
###xml 52 87 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry
###end article-title 102
###begin article-title 103
###xml 44 72 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 82 117 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 162 181 <span type="species:ncbi:9545">pig-tailed macaques</span>
###xml 183 200 <span type="species:ncbi:9545">Macaca nemestrina</span>
Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina)
###end article-title 103
###begin article-title 104
###xml 117 122 <span type="species:ncbi:9606">Human</span>
CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV)
###end article-title 104
###begin article-title 105
###xml 18 46 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 52 87 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 123 137 <span type="species:ncbi:9544">rhesus macaque</span>
Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model
###end article-title 105
###begin article-title 106
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 133 147 <span type="species:ncbi:9544">Macaca mulatta</span>
Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta
###end article-title 106
###begin article-title 107
###xml 7 35 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 49 84 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques
###end article-title 107
###begin article-title 108
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?
###end article-title 108
###begin article-title 109
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Predominance of three NF-kappaB binding sites in the long terminal repeat region of HIV Type 1 subtype C isolates from Zambia
###end article-title 109
###begin article-title 110
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Subtype C Is associated with increased vaginal shedding of HIV-1
###end article-title 110
###begin article-title 111
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D
###end article-title 111
###begin article-title 112
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 101 108 <span type="species:ncbi:9606">infants</span>
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission
###end article-title 112
###begin article-title 113
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 107 112 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression
###end article-title 113

